New audio processor aims to help cochlear implant users hear better in noise
NCT ID NCT04918654
First seen Nov 21, 2025 · Last updated Jun 22, 2026 · Updated 23 times
Summary
This study tested the RONDO 3, a new single-unit audio processor for people with cochlear implants. It includes features like beamforming and noise reduction to help users hear speech in noisy places. Twenty experienced users participated to see if these features improve hearing and satisfaction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCHLEAR IMPLANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MHH - Medizinische Hochschule Hannover
Hanover, 30625, Germany
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RONDO 3 single-unit audio processor with automatic sound management features
What this could lead to
If successful, this could lead to better hearing in noisy environments for cochlear implant users, improving daily communication and quality of life.
What could go wrong
This is a small, completed study with only 20 participants, so results may not apply to all users. The improvements are incremental, not a breakthrough.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.